| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |